UBS Group’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $685K | Buy |
|
|||||
|
2025
Q1 | $96.8K | Buy |
|
|||||
|
2024
Q4 | $49.5K | Buy |
|
|||||
|
2024
Q3 | $577 | Sell |
|
|||||
|
2024
Q2 | $18.8K | Buy |
|
|||||
|
2024
Q1 | $46.8K | Buy |
|
|||||
|
2023
Q4 | $27.1K | Buy |
|
|||||
|
2023
Q3 | $42K | Sell |
|
|||||
|
2023
Q2 | $102K | Sell |
|
|||||
|
2023
Q1 | $191K | Sell |
|
|||||
|
2022
Q4 | $649K | Buy |
|
|||||
|
2022
Q3 | $144K | Buy |
|
|||||
|
2022
Q2 | $90K | Sell |
|
|||||
|
2022
Q1 | $192K | Sell |
|
|||||
|
2021
Q4 | $452K | Buy |
|
|||||
|
2021
Q3 | $198K | Sell |
|
|||||
|
2021
Q2 | $317K | Buy |
|
|||||
|
2021
Q1 | $408K | Sell |
|
|||||
|
2020
Q4 | $419K | Buy |
|
|||||
|
2020
Q3 | $262K | Sell |
|
|||||
|
2020
Q2 | $571K | Sell |
|
|||||
|
2020
Q1 | $538K | Sell |
|
|||||
|
2019
Q4 | $1.34M | Buy |
|
|||||
|
2019
Q3 | $1.01M | Sell |
|
|||||
|
2019
Q2 | $1.92M | Buy |
|
|||||
|
2019
Q1 | $1.31M | Sell |
|
|||||
|
2018
Q4 | $2.64M | Buy |
|
|||||
|
2018
Q3 | $1.55M | Buy |
|
|||||
|
2018
Q2 | $332K | Sell |
|
|||||
|
2018
Q1 | $2.21M | Buy |
|
|||||
|
2017
Q4 | $475K | Sell |
|
|||||
|
2017
Q3 | $1.52M | Buy |
|
|||||
|
2017
Q2 | $258K | Buy |
|
|||||
|
2017
Q1 | $194K | Buy |
|
|||||
|
2016
Q4 | $84K | Buy |
|
|||||
|
2016
Q3 | $9K | Sell |
|
|||||
|
2016
Q2 | $12K | Buy |
|
|||||
|
2016
Q1 | $3K | Sell |
|
|||||
|
2015
Q4 | $41K | Sell |
|
|||||
|
2015
Q3 | $55K | Buy |
|
|||||
|
2015
Q2 | $21K | Buy |
|
|||||
|
2015
Q1 | $5K | Hold |
|
|||||
|
2014
Q4 | $5K | Buy |
|